Medical Disclaimer

genoCDS is a clinical reference tool for qualified healthcare professionals only. Content is derived from published guidelines and regulatory sources and may contain errors or outdated information. It is not a substitute for professional medical judgment, institutional protocols, or individual patient assessment. Always verify recommendations against current primary sources before making clinical decisions. Full disclaimer →

Breast Cancer · Triple-Negative Breast Cancer (TNBC)

Stage Stage IIIB–IIIC

Contralateral mediastinal/supraclavicular nodes, or very locally advanced disease (T3-4/N2-3/M0). Typically unresectable; treated with concurrent chemoradiation ± durvalumab.

0 test recommendations across 0 clinical indications

No recommendations available for this stage yet.

Content is added as guidelines are reviewed and curated. Check back or consult current NCCN guidelines.

Reference only. Testing guidance shown is derived from published clinical guidelines and regulatory sources. It does not constitute a clinical recommendation for any individual patient. Payer coverage information is a general summary and may not reflect current policy or individual benefit design. Full disclaimer

Recommendations on this page are derived from publicly available guidelines (NCCN, ASCO, ESMO, FDA, OncoKB) and are paraphrased for reference. They do not constitute medical advice. Evidence levels reflect the grading systems of each respective organization and should be interpreted in clinical context. This reference is updated periodically but may not reflect the most recent guideline revisions.